New threshold for CXCL13 concentration revolutionizes neuroborreliosis diagnosis Post author: Post published:July 13, 2024 Post category:uncategorized A newly defined threshold for the concentration of the cytokine CXCL13 may improve the diagnosis of neuroborreliosis. You Might Also Like Foam technology revolutionizes gene therapy, boosting efficiency and safety June 3, 2024 Insilico Medicine and Fosun Pharma deliver second preclinical candidate for solid tumor treatment July 6, 2024 Wood cookstove use linked to gastric cancer risk October 4, 2023
Insilico Medicine and Fosun Pharma deliver second preclinical candidate for solid tumor treatment July 6, 2024